Skip to main content
Year archive

PCI Biotech Holding — 2010 filings

All 80 regulatory filings released by PCI Biotech Holding (PCIB) in 2010, sourced directly from the official regulator.

80 Filings
2010 Period
2010 filings (80)
Filing Released Lang
Oppdatering om den pågående fase I/II studien og om forberedelsene for en fase II/III studie av PC-A11
Regulatory Filings
2010-12-21 Norwegian
Update on ongoing Phase I/II study and on preparation for a Phase II/III study of PC-A11
Regulatory Filings
2010-12-21 English
PCI Biotech - Finansiell kalender 2011:
Report Publication Announcement
2010-11-03 Norwegian
PCI Biotech - Financial calendar 2011:
Report Publication Announcement
2010-11-03 English
Mandatory Notification of Trade - Share Options
Director's Dealing
2010-11-02 English
Meldepliktig handel - opsjoner
Director's Dealing
2010-11-02 Norwegian
PCI Biotech Q3 2010 Rapport.pdf (Att: 269326)
Interim / Quarterly Report Q3 2010
2010-10-26 Norwegian
PCI Biotech Q3 2010 Report.pdf (Att: 269325)
Interim / Quarterly Report Q3 2010
2010-10-26 English
PCI Biotech - Resultatrapport for 3.kvartal 2010
Report Publication Announcement
2010-10-26 Norwegian
PCI Biotech - Third quarter 2010
Report Publication Announcement
2010-10-26 English
Meldepliktig handel
Director's Dealing
2010-10-12 Norwegian
Successful completion of the fourth dose group in the Amphinex® study with continued strong tumour response. Further dose escalation is not needed.
Regulatory Filings
2010-09-23 English
Vellykket fullføring av fjerde dosegruppe i Amphinex® studien, med fortsatt kraftig effekt på kreftsvulster. Det er ikke behov for ytterligere doseeskalering.
Regulatory Filings
2010-09-23 Norwegian
PCI Biotech Q2 2010 report.pdf (Att: 266089)
Interim / Quarterly Report H1 2010
2010-08-24 English
PCI Biotech Q2 2010 rapport.pdf (Att: 266088)
Interim / Quarterly Report H1 2010
2010-08-24 Norwegian
PCI Biotech Q2 2010 presentation.pdf (Att: 266088)
Investor Presentation
2010-08-24 English
PCI Biotech - Second quarter 2010 and first half year 2010 results
Report Publication Announcement
2010-08-24 English
PCI Biotech - Resultatrapport for 2.kvartal og første halvår 2010
Report Publication Announcement
2010-08-24 Norwegian
Presentation of second quarter 2010 results
Report Publication Announcement
2010-08-17 English
Presentasjon av resultater for andre kvartal 2010
Report Publication Announcement
2010-08-17 Norwegian
Ny aksjekapital
Share Issue/Capital Change
2010-06-21 Norwegian
New share capital
Share Issue/Capital Change
2010-06-21 English
Endelig resultat i emisjon
Share Issue/Capital Change
2010-06-15 Norwegian
Final results of the rights offering
Share Issue/Capital Change
2010-06-15 English
PCI BIOTECH - PRELIMINARY RESULT OF THE RIGHTS ISSUE
Capital/Financing Update
2010-06-10 English
PCI BIOTECH - FORELØPIGE RESULTATER FRA FORTRINNSRETTSEMISJONEN
Capital/Financing Update
2010-06-10 Norwegian
PCI BIOTECH - EXPIRY OF SUBSCRIPTION PERIOD IN THE RIGHTS ISSUE AND LAST TRADING DAY FOR SUBSCRIPTION RIGHTS
Share Issue/Capital Change
2010-06-09 English
PCI BIOTECH - TEGNINGSPERIODEN I FORTRINNSRETTSEMISJONEN OG HANDELEN AV TEGNINGSRETTER AVSLUTTES I DAG
Share Issue/Capital Change
2010-06-09 Norwegian
Flaggemelding PCIB
Share Issue/Capital Change
2010-06-04 Norwegian
Meldepliktig handel
Director's Dealing
2010-06-04 Norwegian
The subscription rights in the quoted company PCI Biotech Holding ASA will be listed today, 26.05.2010.
Share Issue/Capital Change
2010-05-26 English
Tegningsrettene i PCI Biotech Holding ASA vil bli notert fra og med i dag, 26.05.2010.
Share Issue/Capital Change
2010-05-26 Norwegian
The subscription rights in the quoted company PCI Biotech Holding ASA will be listed tomorrow, 26.05.2010.
Share Issue/Capital Change
2010-05-25 English
Tegningsrettene i PCI Biotech Holding ASA vil bli notert fra og med i morgen, 26.05.2010
Share Issue/Capital Change
2010-05-25 Norwegian
Approved prospectus
Capital/Financing Update
2010-05-25 English
Godkjent prospekt
Share Issue/Capital Change
2010-05-25 Norwegian
Ex subscription rights - PCI Biotech Holding ASA
Share Issue/Capital Change
2010-05-19 English
Eks tegningsretter - PCI Biotech Holding ASA
Share Issue/Capital Change
2010-05-19 Norwegian
Minutes from Extraordinary General Meeting.pdf (Att: 260745)
Declaration of Voting Results & Voting Rights Announcements
2010-05-18 Norwegian
Protokoll fra ekstraordinaer generalforsamling.pdf (Att: 260744)
Declaration of Voting Results & Voting Rights Announcements
2010-05-18 Norwegian
Guaranteed rights issue of NOK 90 million resolved in an Extraordinary General Meeting.
Capital/Financing Update
2010-05-18 English
Garantert fortrinnsrettsemisjon på NOK 90 millioner vedtatt i ekstraordinær generalforsamling
Share Issue/Capital Change
2010-05-18 Norwegian
Annual overview.pdf (Att: 259385)
Fund Information / Factsheet
2010-04-30 Norwegian
Annual overview
Audit Report / Information FY 2009
2010-04-30 English
Årsoversikt
Audit Report / Information FY 2009
2010-04-30 Norwegian
Call for Extraordinary General meeting.pdf (Att: 258793)
Proxy Solicitation & Information Statement
2010-04-27 Norwegian
Innkalling til ekstraordinaer generalforsamling.pdf (Att: 258792)
Proxy Solicitation & Information Statement
2010-04-27 Norwegian
Notice of Extra Ordinary General Meeting
AGM Information
2010-04-27 English
Innkalling til ekstraordinær generalforsamling
AGM Information
2010-04-27 Norwegian
Generalforsamlingsprotokoll 2010.pdf (Att: 258791)
AGM Information
2010-04-27 Norwegian
Generalforsamling avholdt i PCI Biotech Holding ASA
AGM Information
2010-04-27 Norwegian
PCI Biotech Q1 2010 report.pdf (Att: 258742)
Interim / Quarterly Report Q1 2010
2010-04-27 English
PCI Biotech Q1 2010 rapport.pdf (Att: 258741)
Interim / Quarterly Report Q1 2010
2010-04-27 Norwegian
PCI Biotech - First quarter 2010
Report Publication Announcement
2010-04-27 English
PCI Biotech - Resultatrapport for 1.kvartal 2010
Report Publication Announcement
2010-04-27 Norwegian
Guaranteed rights issue of NOK 90 million in PCI Biotech Holding ASA
Share Issue/Capital Change
2010-04-23 English
Garantert fortrinnsrettsemisjon på 90 millioner kroner i PCI Biotech Holding ASA
Capital/Financing Update
2010-04-23 Norwegian
Selskapsoppdatering
Regulatory Filings
2010-04-21 Norwegian
Company update
Regulatory Filings
2010-04-21 English
OSLO BØRS - MATCHING HALT ENDS
Regulatory Filings
2010-04-06 English
Company update
Capital/Financing Update
2010-04-06 English
Selskapsoppsdatering
Capital/Financing Update
2010-04-06 Norwegian
OSLO BØRS - MATCHING HALT
Regulatory Filings
2010-03-31 English
Aarsrapport 2009.pdf (Att: 256900)
Annual Report FY 2009
2010-03-25 Norwegian
Innkalling til generalforsamling.pdf (Att: 256900)
Proxy Solicitation & Information Statement
2010-03-25 Norwegian
Notice of Annual General Meeting.pdf (Att: 256899)
Proxy Solicitation & Information Statement
2010-03-25 Norwegian
Annual Report 2009.pdf (Att: 256899)
Annual Report FY 2009
2010-03-25 Norwegian
Innkalling til ordinær generalforsamling
Report Publication Announcement
2010-03-25 Norwegian
Notice of Ordinary General Meeting
Report Publication Announcement
2010-03-25 English
Successful completion of the third dose group in the Amphinex study. Continued good tolerability and strong tumour response is reported, with an apparent high treatment specificity for cancer cells
Regulatory Filings
2010-03-16 English
Vellykket fullføring av tredje dosegruppe i Amphinex-studien. Fortsatt god toleranse og kraftig effekt på kreftsvulster er rapportert, og det ser ut til at det er en høy spesifisitet for kreftceller.
Regulatory Filings
2010-03-16 Norwegian
PCI Biotech Q4 2009 rapport.pdf (Att: 254520)
Interim / Quarterly Report Q4 2009
2010-02-19 Norwegian
PCI Biotech Q4 2009 report.pdf (Att: 254519)
Interim / Quarterly Report Q4 2009
2010-02-19 English
PCI Biotech - Resultatrapport for 4.kvartal 2009 og foreløpig årsresultat for 2009
Report Publication Announcement
2010-02-19 Norwegian
PCI Biotech - Fourth quarter 2009 and preliminary full year 2009 results
Report Publication Announcement
2010-02-19 English
Oppdatert investorpresentasjon
Investor Presentation
2010-01-21 Norwegian
100121 PCIB ppt FINAL.pdf (Att: 252823)
Investor Presentation
2010-01-21 English
Updated investor presentation
Report Publication Announcement
2010-01-21 English
PCI Biotech reports successful completion of second dose group in a Phase I/II Amphinex® trial. Strong anti-tumour response observed in all patients
Regulatory Filings
2010-01-19 English
PCI Biotech rapporterer om vellykket fullføring av andre dosegruppe i fase I/II studien med Amphinex®. Kraftig effekt er observert på alle behandlede kreftsvulster
Regulatory Filings
2010-01-19 Norwegian